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5Chairman and CEO: 
overview and outlook
As we progressed through 2008, it became clear that Ireland’s 
economic outlook was not as bright as it had been in previous 
years and that the Government would have to make some tough 
decisions about where to allocate resources. The HRB would have 
to maximise the benefit derived from existing Department of 
Health and Children funding. It would also have to be smart, sharp 
and innovative in its approach to sourcing funding and building 
collaborations with others. 
When we invest in health research, we invest in the future of Irish healthcare, and it 
is important that we don’t lose sight of this. It was with this thought in mind that the 
HRB embarked on a review of future strategy, and began to examine in earnest how 
it could use the funding allocated to it in the best way possible to improve health and 
transform healthcare.
The strategic review was led by the HRB’s new CEO, Enda Connolly, who was appointed 
in June. He brought to the organisation more than 30 years’ experience of working 
in IDA Ireland, where he played a pivotal role in leading change, developing strategy, 
building stakeholder confidence and securing significant foreign direct investment.
Since taking up his appointment with the HRB, his main focus has been on getting 
to grips with the health research sector and also with Ireland’s changing economic 
circumstances, while strategically positioning the HRB to deliver a step change in 
health research. Specifically, he aims to increase research capacity in the health 
services and create an environment that can absorb innovation, deliver better service 
and improve patient care. 
6In this way, he believes that not only can the HRB support the transformation of Irish 
healthcare, it can also create the perfect platform to attract healthcare industries to 
Ireland and in doing so further Irish economic development.
This report contains a summary of some of the HRB’s achievements in 2008. However, 
it by no means captures the full extent of activity across the organisation, or the 
commitment of staff who have demonstrated patience, resolve and focus during a 
period of enormous change and while operating with increasingly difficult resource 
restraints. We would like to take this opportunity to thank them for their work ethic 
and for their resolve. 
The Board have demonstrated solid leadership throughout the year, and have continued 
to drive new and better standards of corporate governance across all aspects of the 
HRB’s business activities. We recognise the value of their contribution and we would 
like to express our genuine thanks for their support throughout the year.
We are committed to leading a step change in health research in Ireland and to 
bringing research and development to life.
Dr Reg Shaw 
Chairman
Mr Enda Connolly
Chief Executive
7Funding research excellence
During 2008, the HRB invested almost €43 million in health research awards projects, 
bringing its total funding commitment across the Irish health research system to 
more than €155 million. This investment will help develop existing health research 
infrastructure and will underpin the development of research staff across Ireland’s 
health services; it will also ensure that the HRB’s research projects are of the highest 
quality, and will thus facilitate the delivery of improved health services and better 
health outcomes for people in Ireland. 
As in previous years, all investments were made on the basis of stringent international 
peer-review processes. Of the 841 applications received during the year, a total of 
343 were allocated funding support. A full breakdown of the funding awarded is set 
out in Appendix A. This illustrates the number and variety of new health professionals, 
as well as details of the type of infrastructure projects and research programmes 
supported in 2008. 
Outlined below are examples of some of the major new research initiatives funded 
during the year. 
New clinical research facility, Cork
 In 2008, the HRB announced joint funding with the HSE of a new Clinical 
Research Facility (CRF) in Cork. The joint investment, totaling almost €11 
million over five years, will cover construction-related costs, equipment and 
the commissioning of facilities, as well as supporting experts who will facilitate 
patient-focused studies. 
 The new facility will provide a way for clinicians, the healthcare industry and other 
key partners to test innovative therapies, technologies and products, and increase 
the speed at which scientific discoveries and innovations can be translated into 
better patient care. It will also make a real contribution to postgraduate research 
and to the training of health professionals.
 The CRF will concentrate on patient-oriented research. Medical doctors and nurses 
will work with other scientists to improve our understanding of cancer, heart 
disease, bowel disease and nutrition. CRF researchers will develop new tests and 
will also provide patients with access to the latest advances in treatments to help 
tackle these diseases. 
8Joint HRB/HSE Fellowships
 In 2008, the HRB and the HSE launched a joint fellowship scheme which enables 
medical graduates to undergo the specialist training required to attain consultant 
status while simultaneously carrying out PhD research. Prior to the introduction of 
the scheme, a medical graduate had to step out of specialist training, or postpone 
entering specialist training, if he or she wished to do a PhD. Now, with the 
introduction of the joint fellowship scheme, this is no longer necessary. In addition, 
medical graduates have a new track for career development – one that integrates 
research as a central pillar of their specialist training.
Innovative networks to co-ordinate research efforts
  
At the launch of the HRB research networks 
Dr Mairead O’Driscoll, Director of Research 
Strategy and Funding, Minister Mary Harney, 
Prof Ivan Perry, Principal Investigator of the 
HRB Centre for Diet, Diabetes and Obesity.
 
During 2008, the HRB also launched two new research networks; these provide 
a focal point for research on a common health priority, which is conducted across 
a number of disciplines and institutions. The two networks comprise a virtual 
network of researchers, who work in a co-ordinated manner on different aspects 
of a common health priority. By concentrating their expertise and effort on 
particular issues, these research networks will help to achieve economies of 
scale and will encourage information sharing which, ultimately, will lead to 
improvements in patient care.
 The first of these networks, the HRB Centre for Primary Care Research, 
is based at the Royal College of Surgeons in Ireland. This research team will 
undertake a programme of work that examines the quality of care provided to 
vulnerable patient groups – the elderly, children, pregnant women and drug users.
 The second network, the HRB Centre for Diet, Diabetes and Obesity, will 
have its virtual base in University College Cork. The aim of the centre, which will 
be co-funded by the Department of Agriculture, Fisheries and Food, is to produce 
internationally competitive research which will contribute to the evidence base 
for public policy, health promotion and clinical practice on the prevention and 
management of obesity, diabetes and related metabolic disorders.
9Generating information for policy
Sound evidence and high-quality information are central to good decision-making on 
health issues. 
The HRB manages five national information systems which provide the most up-to-date 
evidence for service planning and decision-making on issues such as alcohol and drug 
use, mental health and disability. The real benefit of these information systems is that 
they can provide clear evidence about the areas where additional services are needed 
most. The information provided enables health service managers and policy-makers to 
make more effective decisions about services for the people who need them. A full list 
of the reports published by the HRB or published in journals is set out in Appendix B. 
The full text of HRB reports is available on the HRB website: www.hrb.ie/publications.
Initiatives completed during 2008 
The sample case studies outlined below illustrate some of the other evidence-driven 
initiatives completed during 2008.
First comprehensive report on drug-related deaths
 In 2005, the HRB was requested to develop a National Drug-Related Deaths Index, 
which would provide a more accurate mechanism for recording both drug-related 
deaths and deaths among drug users. In 2008, the HRB reported the first findings, 
which show that over the eight-year period 1998 to 2005, a total of 2,442 people 
died either directly or indirectly from drug use. In all, 1,553 deaths were directly 
linked to the consumption of drugs, either on their own or combined with other 
substances (poisoning); 889 deaths were indirectly attributed to drug use (non-
poisoning). 
 The report contains a detailed breakdown of cause of death, in addition to 
information on the associated drug use and socio-economic background of those 
who died from poisonings. Overall, the evidence gathered indicates that the most 
significant response needed relates to overdose. It is essential to establish what the 
root causes are in relation to overdose and develop actions to deal with potential 
overdose cases in a more proactive manner.
10
New evidence base to tackle crack cocaine
 
While the crack cocaine market has not taken 
hold in Ireland to the extent that it has in other 
countries, the HRB was asked to gather evidence 
and information on this market, in order to 
inform practice and ensure that this situation 
doesn’t change. The report prepared by the HRB 
provides a very clear picture of the nature and 
extent of crack cocaine use in Ireland and the 
consequences of such use for users, families 
and society. The report will be central to the 
development of a timely, strategic response to 
the crack cocaine market, to be outlined in the 
new National Drugs Strategy which is being 
developed for the period 2009–2016.
Needs of children aged 0-5 years with intellectual disability
 The HRB reviewed and reported on 
the service needs of children aged 
0-5 years who have an intellectual 
disability. The main finding reported 
was the importance of carrying out a 
needs assessment on these children 
early on in their development. 
 The evidence gathered by the HRB 
points to the importance of continued 
investment in, and expansion of, services for this age group – particularly for 
services such as speech and language therapy and occupational therapy. The 
highest levels of unmet need are linked to the provision of home support and 
respite care. Many children who are already receiving day services require changes 
to be made to the type of services they are currently provided with. 
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Use of the Internet to investigate mental health problems
 An HRB report published in 2008 sought to establish the socio-economic 
breakdown of people who use the Internet to find out more about health 
and mental health issues that are of particular relevance to them. The report 
showed that more than one in four Irish adults had used the Internet to search 
for information about health issues, and 60% of Internet users who reported 
mental health problems had used the Internet as a source of information about 
health issues. 
The report highlights two important points:
1. In Ireland there is still a major digital divide between those who use the 
Internet (younger people in employment with higher levels of education) and 
those who don’t (older adults and people with lower educational levels, or 
those who are unemployed). Evidence would suggest that it is important to 
develop and extend current ICT initiatives in order to reduce inequalities in 
Internet availability and usage. 
2. People who use information sourced on the Internet for health-related 
decision-making purposes without seeking expert advice run the risk of this 
having a negative impact on their health. Evidence would suggest that if use of 
the Internet is to be encouraged as a source of health information, it is critical 
that the information available on Irish websites is evaluated and assessed 
by experts, so that it is possible to guide people towards information that is 
correct, credible and practical from an Irish perspective. 
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Health Research: making an impact 
Each year the HRB monitors the impact of research projects that 
have been completed. Impact is measured under the following category 
headings: health benefits; economic benefits; knowledge production; 
capacity building and informing policy and practice. Set out below are 
some illustrative examples of the type of impact that this research 
has created. 
Impact Category: HEALTH BENEFITS
Improved health, cost reduction in delivering existing services, qualitative 
improvements in the process of delivery, improved equity in service delivery.
1,000 patients took part in • 
randomised control trials which 
examined the effectiveness of new 
healthcare interventions 
969 patients were recruited to • 
participate in cancer clinical trials 
Seven treatments for different • 
diseases are in development 
Four diagnostic systems are in • 
development (e.g. biomarkers 
for disease) 
One new patient booklet, which • 
is distributed to pharmacies 
One website for adolescents • 
reporting sexual abuse
Development of a three-phase plan • 
for rare disorders (information website, 
family support service, national centre 
for rare disorders)
Three grants identified potential cost • 
efficiencies to the health system. 
Example: An HRB-funded randomised 
control trial, which examined a GP-based 
intervention aimed at the prevention 
of secondary heart disease (SPHERE), 
recruited over 900 patients and found that 
patients who received the intervention 
were less likely to be admitted to hospital 
than control patients.
Example: Pre-clinical development and 
validation of a novel gene therapy for 
common eye diseases, such as retinitis 
pigmentosa, which lead to blindness in 
those who are affected. 
Example: A new form of treatment for 
cancer which is now ready to test in 
clinical trials.
Example: One research grant led to 
the production of a patient information 
booklet entitled Let’s talk Medication 
Safety. The booklet is designed to address 
a gap in patients’ knowledge concerning 
the basis and safety of some medicines. 
13
Impact Category: ECONOMIC BENEFITS
Wider economic benefits from the commercial exploitation of innovations 
arising from R&D; economic benefits as a result of having a healthy workforce 
and a reduction in working days lost.
Five patents (two awarded, • 
one filed, two innovation disclosures)
One licence agreement with industry• 
One spin-out campus company • 
in development
Five industry-academia • 
collaborations established 
12 grant holders secured additional • 
funding from overseas agencies
Example: Several patent applications 
have been submitted by one HRB 
research group, including a patent 
application for a new method of 
biosensor manufacture. The group also 
have four licence agreements involving 
biosensors; the agreements, which are 
valued at over €150,000, are with Solvay 
Pharmaceuticals in the Netherlands. 
In addition, funding from Enterprise 
Ireland has enabled the research group to 
develop a spin-out campus company to 
capitalise on this technology. 
Example: One principal investigator 
secured a European Research Council 
fellowship grant of €1 million as a result 
of their HRB project. Securing this 
grant was a major success, given the 
competitive nature of such awards.
Impact Category: KNOWLEDGE PRODUCTION
Journal articles, conference presentations, books, book chapters, 
research reports.
Outputs:
310 peer-reviewed publications • 
20 book chapters• 
21 non-scientific reports, letters • 
and bulletins 
Representation at national and • 
international conferences
52 keynote talks • 
343 oral presentations• 
302 poster presentations• 
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Impact Category: CAPACITY-BUILDING 
Development of research skills, personnel and overall research capacity; 
staff development and educational benefits 
Outputs:
Higher degrees: • 40 PhDs; three MDs, three Masters
New international collaborations formed:•  125
Additional research personnel:•  61 post-doctoral researchers; 29 research 
assistants; 10 research nurses/clinical researchers; six project managers or 
technicians; two Cochrane Fellows
Researchers retained in national research system:•  19 out of a total of 
48 postgraduate students (i.e. 40% retention rate); 64 out of a total of 106 other 
personnel such as postdoctoral students (i.e. 60% retention rate)
New researchers recruited from overseas to work on grants: • eight out of 
48 postgraduate students (i.e. 17%); 18 out of 106 ‘other’ personnel (i.e. 17%)
Number of grants leveraged from HRB funding (reported by 46% of grant • 
holders): 50 national grants, 12 international grants (e.g. Wellcome Trust €300,000)
Use of research techniques by group: • 
new to research group (32% of grant 
holders); new to Ireland (20% of grant 
holders); new to field worldwide (8% 
of grant holders)
Establishment of new databases • 
(reported by 3% of grant holders)
Example: Researcher developed a more 
effective methodology to improve the 
analysis and interpretation of PET scans.
Examples: A prostate cancer information 
system and the WISDOM mental health 
information system
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Impact Category: INFORMING POLICY AND PRACTICE
Improved information bases for political and executive decisions, developing 
pharmaceutical products and therapeutic techniques
One in ten grant holders reported • 
generating evidence or cost-
effectiveness data to support policy 
development or health service 
provision.
One in five grant holders reported • 
contributions to clinical practice 
and health service delivery through 
the development of new treatments, 
interventions or clinical guidelines.
Dissemination of research to ‘users’ • 
such as policy-makers:
three meetings with research ‘users’• 
four publications in HSE newsletters• 
three ‘grey literature’ reports • 
three training manuals for health • 
professionals
Eight grant holders reported that they • 
had established an advisory role to 
policy-makers or central government 
on health-related issues
Example: Data generated from an HRB 
Programme on Healthy Ageing was 
used for policy development by the 
Cardiovascular Health Policy Group 
(2007/2008). The principal investigator 
on this HRB programme is acting as 
Chair of the new ten-year national 
cardiovascular policy which was launched 
in late 2008 by the Department of Health 
and Children.
Example: A researcher who carried 
out a Cochrane systematic review 
on the prevention of intravascular 
catheter-related infections was invited 
to join a Committee (Health Protection 
Surveillance Centre) that is currently 
developing guidelines for the prevention 
of such infections in Ireland.
Example: One research group study 
resulted in the production of a training 
manual for health professionals entitled 
Supporting persons with intellectual 
disability and advanced dementia: 
Fusing Horizons of care. An Introductory 
Education and Training programme. 
Trainer’s Manual: Trinity College Dublin. 
Example: On the basis of evidence 
generated as part of their HRB research 
programme, two researchers were 
asked to provide advice to key HSE 
personnel, and also provide input on 
quality of life and quality of care issues 
for Irish patients in relation to the 
formulation of the HSE Heart Failure 
Action Plan 2008–2011. 
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Picture of Health
The HRB’s Picture of Health publication 
encompasses a wide variety of key 
outcomes and impacts of health research 
projects and programmes completed 
during the year. This publication 
is available online at www.hrb.ie/
publications
Making an impact report
During 2008, the HRB published a report 
Health Research - Making an impact: the 
economic and social benefits of HRB-funded 
research. This assessed the cumulative 
outcomes of a selection of HRB funded 
research projects over time to demonstrate 
the impact that HRB funding is having on 
people’s health and the Irish economy. It 
is the first Irish study of its kind. Using a 
pioneering approach called the ‘Payback 
Framework’, the HRB worked with the 
Health Economics Research Group in 
Brunel University and RAND Europe to 
identify and assess these benefits. The 
findings of the report are published online 
at www.hrb.ie/publications
17
Summary of outputs from grants completed in 2008 
Output Type 2007 2008
Number of ‘end of grant’ reports received:
Project grants
Fellowships
Programmes
Partnership awards
Medical Research Charities Group 
Health information systems
Ireland-Northern Ireland 
Cooperation Research Project Grants
55
36
17
2
93
49
22
8
7
2
3
2
Total number of post-graduate students funded 
Total number of these postgraduates who are PhD students 
42
31 
48
42 
Total number of personnel funded
Number of these personnel who are 
post-doctoral researchers
Number of these personnel who are ‘other’ 
e.g. research nurses 
45
31
14
108
61
47
Total number of peer-reviewed publications 
Average number of peer-reviewed publications per grant
134
2.4
303
3.3
Number of international presentations delivered
Average number of peer-reviewed publications per grant
216
3.9
431
4.6
Number of new collaborations formed from grant
National
International 
98
39
59
197
72
125
Number of patent applications filed/intend to file 2 5
18
54%
24%
9%
8%
2% 3%
Project grants
Fellowships
Programmes
Partnership awards
Medical research charities group
Health information systems
Figure 1 Types of grants completed in 2008 
Figure 2 Outputs from grants completed in 2008
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Appendix A 
Award Schemes 2008
Career support schemes and capacity building
Applicants Awards
Cochrane fellowships 15 5
Summer student scholarship 147 50
NCI summer curriculum (Cancer Consortium) 14 14
Post-doctoral research fellowships 40 8
Clinical research training fellowships 32 4
Health services research fellowships 18  4*
Health economics fellowships 10 2
Clinical fellowships in nursing and midwifery 21 3
Cancer prevention fellowship (Cancer Consortium) 0 0
Clinical scientists awards 12 4
309 94
* Includes one palliative care fellowship co-funded by the Irish Hospice Foundation 
Appendix A Award schemes 2008 continued overleaf.
20
Research grants   
Applicants Awards
Building partnerships for a healthier society awards 31 6
Global health networking awards 13 11
Project grants 260 45
Joint research project on cancer 7 2
311 64
Infrastructure grants  
 Applicants Awards
Methodology support centre 2 1
 2 1
Training and workshops  
Applicants Awards
HRB scientific writing workshops 104 80
Cochrane two-day course on systematic reviews 55 44
Half-day ‘Introduction to Cochrane’ collaboration 60 60
Nursing clinical trials training (Cancer Consortium) 0 0
219 184
Appendix A 
Award Schemes 2008 (continued)
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Revenue Income 
and Expenditure Account
for the year ended 31 December 2008
2008 2007 
 €  € 
INCOME
Department of Health and Children Revenue Grant  36,884,529  36,085,000 
Other Research Funding  2,856,861  3,033,254 
Interest Receivable  55,164  35,188 
Rental Income -  37,552 
Proceeds from Insurance Claim  42,500  - 
Transfer to Capital Reserves of Amount Allocated to 
Fund Fixed Assets
 -  (55,679)
 
 39,839,054  39,135,315 
EXPENDITURE
Research Strategy and Funding Directorate  32,886,411  32,004,323 
Health Information Systems and In-House Research 
Directorate
 3,942,935  3,650,086 
Corporate Function Directorate  3,138,340  3,400,850 
Pensions Paid to Retired Members of Staff  (135,169)  69,892 
 39,832,517  39,125,151 
SURPLUS FOR THE YEAR  6,537  10,164 
Revenue reserve at 1 January  42,660  32,496 
REVENUE RESERVES AT 31 DECEMBER  49,197  42,660 
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Capital Income and 
Expenditure Account
for the year ended 31 December 2008
  
2008 2007 
  €  € 
INCOME
Department of Health and Children Capital Grant 12,439,199 10,406,696 
Amortisation of Capital Fund Account  155,578  119,497 
Contribution to Fund Fixed Assets  (158,683)  (30,238)
12,436,094 10,495,955 
EXPENDITURE
Equipment Grants and Start-Up Funding  155,171  595,103 
Clinician Scientist Awards 2,479,348  2,212,205 
Imaging Awards 1,086,153  1,552,433 
Health Services R&D Awards 1,616,005  1,620,805 
PhD Scholars Programme 2,579,085  1,456,899 
Translational Research Awards 2,959,444  2,337,515 
Methodology Support Centre Award  599,330  - 
Clinical Research Facilities  315,000  200,000 
Commissioned Research  101,247  127,372 
ICT Development  344,703  274,126 
Refurbishment Costs  45,030  - 
Depreciation  116,240  109,303 
Loss on Disposal of Fixed Assets  39,338  10,194 
12,436,094 10,495,955 
(DEFICIT)/SURPLUS FOR THE YEAR  -  - 
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Balance Sheet
for the year ended 31 December 2008
2008 2007 
  €  € 
FIXED ASSETS
Tangible assets  323,649  320,544 
CURRENT ASSETS
Debtors  436,933  550,196 
Investments  641  641 
Cash at bank and on hand  500  400 
 438,074  551,237 
CURRENT LIABILITIES
Amounts falling due within one year:
Bank  11,569  17,807 
Creditors  377,308  490,770 
 388,877  508,577 
NET CURRENT ASSETS  49,197  42,660 
NET ASSETS  372,846  363,204 
RESERVES
Accumulated surplus on 
Income and expenditure account  49,197  42,660 
Capital fund  323,649  320,544 
 372,846  363,204 

de
si
gn
 b
y 
dr
aw
in
gi
nc
www.hrb.ie
